American Medical Systems discovers life after Pfizer
This article was originally published in Clinica
Executive Summary
Private urological company American Medical Systems claims to have transformed itself in the 18 months since it was sold by Pfizer. "We have changed the company from a Pfizer-like organisation into an independent minded company," said Douglas Kohrs, AMS's president and CEO, at the US bancorp Piper Jaffray Health Care conference in New York earlier this month. "In the last six months we have made three technology acquisitions - that wouldn't have been possible with Pfizer."